Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow.

3CR Bioscience Ltd. are delighted to announce a groundbreaking collaboration with MolBreeding Biotech Ltd. and HC Scientific to establish a new, cutting-edge lab facility in Europe opening at the end of 2023.

The ScaleBio Seq Suite will allow researchers to upload fastq and BCL files and easily analyze their single-cell data produced using ScaleBio’s patented and disruptive combinatorial indexing technology.

Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms.

HeartCare Combines Testing Using Both AlloMap Gene Expression Profiling and AlloSure Donor-Derived Cell-Free DNA.

The Onso Platform Delivers Extraordinary Accuracy Which Creates New Possibilities for Research and Translational Sequencing Applications.

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), announced the signing of a strategic partnership with Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies.

Revvity announced the launch of the Fontus™ Automated Liquid Handling Workstation, designed to deliver easier and faster workflows which enable better results for next generation sequencing (NGS) and diagnostic research applications.

New ready-to-ship xGen™ NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow.

PrecisionLife, has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome.